Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vivani MedicalSTU:U5P -6.40%35 3-1 Month Momentum % is 24.10% as of Sep. 09, 2026. GuruFocus rates STU:U5P with a GF Score™ of 35/100. The stock has 1 warning sign investors should review. Among 1,386 Biotechnology companies, Vivani Medical ranks better than 79.08% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-09), Vivani Medical's 3-1 Month Momentum % is 24.10%.
The industry rank for Vivani Medical's 3-1 Month Momentum % or its related term are showing as below:
STU:U5P's 3-1 Month Momentum % is ranked better than 79.08% of 1386
companies
in the Biotechnology industry
Industry Median: 1.085
vs STU:U5P: 24.10
Vivani Medical (STU:U5P) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Vivani Medical 3-1 Month Momentum % Related Terms
STU:U5P vs BDTX, VTVT, TLSA: 3-1 Month Momentum % Comparison
For the Biotechnology subindustry, Vivani Medical's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vivani Medical 3-1 Month Momentum % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vivani Medical's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Vivani Medical's 3-1 Month Momentum % falls into.
Vivani Medical (STU:U5P) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivani Medical (STU:U5P) has a 3-1 Month Momentum % of 24.10% as of Sep. 09, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Vivani Medical and its competitors. According to the industry distribution chart, Vivani Medical ranks #290 out of 1386 companies in the Biotechnology industry, placing it in the top 20.9%.
Is Vivani Medical's 3-1 Month Momentum % too high?
Vivani Medical's current 3-1 Month Momentum % is 24.10%. The Biotechnology industry median 3-1 Month Momentum % is 1.09. Vivani Medical's value of 24.10% is 2121.2% above this industry median. Based on the distribution chart, Vivani Medical ranks #290 out of 1386 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Vivani Medical has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Vivani Medical's 3-1 Month Momentum % compare to BDTX and VTVT?
According to the Biotechnology industry distribution chart, Vivani Medical ranks #290 out of 1386 companies for 3-1 Month Momentum %. This places Vivani Medical in the top 21% of its industry — outperforming the majority of peers. The industry median 3-1 Month Momentum % is 1.09. Vivani Medical's value of 24.10% is 2121.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
The median 3-1 Month Momentum % among Biotechnology companies is 1.09, based on 1,386 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vivani Medical's current 3-1 Month Momentum % of 24.10% is 2121.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Vivani Medical and its competitors. For the Biotechnology industry, the median 3-1 Month Momentum % is 1.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vivani Medical's current 3-1 Month Momentum % is 24.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivani Medical stock overvalued right now?
Vivani Medical (STU:U5P) has a current 3-1 Month Momentum % of 24.10%. The current 3-1 Month Momentum % is 24.10% and 2121.2% above the Biotechnology industry median of 1.09. Vivani Medical's overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Vivani Medical (STU:U5P), the current 3-1 Month Momentum % is 24.10% as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
35GF Score
Get the complete analysis for STU:U5P
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:U5P has been successfully added to your 
